Kineta

Kineta

Aims at developing edge therapeutics in autoimmune disease, viral disease, and chronic pain areas.

HQ location
Seattle, United States
Website
kinetabio.com
Launch date
Employees
11-50 people
Market cap
$9.4m
Enterprise value
$9m
Share price
$0.57 KA
Recent deals
https://twitter.com/kinetabiohttps://www.facebook.com/kinetabiohttps://www.linkedin.com/company/kinetabio/
Authorizing premium user...